Breaking News

Eurofins CDMO Alphora to Construct New GMP Biologics Manufacturing Facility

The 50,000 sq ft facility in Mississauga, Ontario is scheduled for completion in April 2026.

Author Image

By: Charlie Sternberg

Associate Editor

Eurofins CDMO Alphora Inc. has announced plans to construct a new GMP Biologics manufacturing facility in Mississauga, Ontario, to manufacture monoclonal Antibodies (mAbs) and protein therapies for clinical and commercial applications.   This investment is supported by the Federal Government of Canada and a contribution through the Strategic Initiative Fund (SIF). The facility is designed to bolster Canada’s biomanufacturing capabilities and preparedness for future pandemics while streng...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters